Clinic-based burden of glaucoma among Sahrawi refugees in the Tindouf camps Authors: Ouafa Mhamdi-Lehebib, Carmen Mendez-Hernandez Published: 2026 ABSTRACT AbstractObjectiveTo estimate the clinic-based frequency of glaucoma among Sahrawi refugees attending humanitarian ophthalmology missions in the Tindouf camps (Algeria), to identify demographic and clinical factors associated with glaucoma and to contextualise the clinic-based frequency of other ophthalmic diseases.Methods and analysisWe conducted a clinic-based cross-sectional study among Sahrawi refugees during Médicos del Mundo ophthalmology missions. All participants underwent a standardised ophthalmological examination including targeted history, visual acuity assessment, slit-lamp biomicroscopy and intraocular pressure (IOP) measurement. Glaucoma diagnosis relied on structural optic nerve head assessment and elevated IOP, with independent confirmation by a second ophthalmologist. Age-standardised and sex-standardised clinic-based frequencies were calculated using camp population demographics. Multivariable logistic regression identified factors associated with glaucoma.ResultsA total of 900 symptomatic care-seeking individuals were examined (56% men; median age 70 years). Overall clinic-based glaucoma frequency was 13.3% (95% CI 11.1% to 15.5%), representing the main disease of interest. After standardisation, the estimated clinic-based frequency was 6.7% (95% CI 3.8% to 9.7%). Older age was independently associated with glaucoma (adjusted OR per year 1.02; 95% CI 1.01 to 1.03; p=0.003). Inverse associations with cataract and keratopathy, likely reflected selection patterns and diagnostic overshadowing. Cataract was the most common coexisting diagnosis (59.8%), followed by keratopathy (9.1%) and retinopathy (3.4%). Among participants, 37.8% (n=340) had severe bilateral visual impairment, and 40.9% (n=368) had monocular vision; 17.5% (n=60/340) of those with bilateral impairment were blind from glaucoma.ConclusionsGlaucoma represents a substantial clinic-based burden among symptomatic Sahrawi refugees attending humanitarian missions, with a high proportion of irreversible visual loss. Other ophthalmic conditions were common but functioned as coexisting causes of visual impairment in this care-seeking sample. These findings highlight the need for pragmatic, context-appropriate strategies for opportunistic glaucoma detection and continuity of care in refugee settings, acknowledging limitations including the non-probabilistic, mission-based sampling and absence of visual-field testing.Keywords: Cataract, Glaucoma, Public health, Vision, Epidemiology, Intraocular pressure, Optic Nerve WHAT IS ALREADY KNOWN ON THIS TOPIC Glaucoma burden is higher in low-resource and humanitarian settings where early detection and long-term care are limited. Glaucoma burden is higher in low-resource and humanitarian settings where early detection and long-term care are limited. No previous data exist on the clinic-based frequency or distribution of glaucoma and other major ophthalmic diseases among Sahrawi refugees living in protracted displacement in the Tindouf camps. No previous data exist on the clinic-based frequency or distribution of glaucoma and other major ophthalmic diseases among Sahrawi refugees living in protracted displacement in the Tindouf camps. WHAT THIS STUDY ADDS This clinic-based cross-sectional study reveals a substantial burden of glaucoma with irreversible visual loss among symptomatic Sahrawi refugees attending humanitarian ophthalmology missions. This clinic-based cross-sectional study reveals a substantial burden of glaucoma with irreversible visual loss among symptomatic Sahrawi refugees attending humanitarian ophthalmology missions. After age and sex standardisation, the estimated clinic-based frequency of glaucoma was 6.7%, and one-third of glaucoma patients presented with bilateral low vision. After age and sex standardisation, the estimated clinic-based frequency of glaucoma was 6.7%, and one-third of glaucoma patients presented with bilateral low vision. HOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICY Findings underscore the need for pragmatic, resource-appropriate glaucoma detection strategies within humanitarian eye-care programmes. Findings underscore the need for pragmatic, resource-appropriate glaucoma detection strategies within humanitarian eye-care programmes. Integrating opportunistic glaucoma screening into cataract-care pathways and ensuring continuity of treatment could reduce irreversible blindness in displaced populations. Integrating opportunistic glaucoma screening into cataract-care pathways and ensuring continuity of treatment could reduce irreversible blindness in displaced populations. Introduction Glaucoma is the leading cause of irreversible blindness in many regions worldwide. In Europe, the estimated prevalence of glaucoma is 2.99% making it one of the most common causes of blindness and visual impairment worldwide.1,3 The disease is often asymptomatic in its early stages, underscoring the importance of early diagnosis and population-based screening programmes.4 Socioeconomic disparities further exacerbate disease progression, as low-income populations and minority groups face reduced access to early screening and treatment.5 The humanitarian crisis affecting the Sahrawi refugee population in the Tindouf camps, Algeria, is one of the longest standing in the world. Health planning and care are hampered by the lack of updated population data. According to data from the United Nations High Commissioner for Refugees and official sources in the Sahrawi Arab Democratic Republic (SADR), the estimated population in the Sahrawi camps is approximately 173 000 people.6 Refugee populations, such as the Sahrawi community in Tindouf, face heightened health vulnerabilities. These are due to climate-related displacement and systematic exclusion from national health systems.7 Therefore, ophthalmic diseases may disproportionately affect this population. Currently, no data are available on the clinic-based frequency of glaucoma or other ocular diseases among Sahrawi refugees. This study aims to estimate the clinic-based frequency of glaucoma among Sahrawi refugees evaluated during ophthalmology missions in October 2024 and May 2025, and to identify the demographic and clinical factors associated with a glaucoma diagnosis in this care-seeking population. A secondary contextual aim is to describe the most common coexisting ophthalmic diseases observed among patients who sought eye care in the Tindouf refugee camps. Materials and methods To address the objectives of this study, we conducted a cross-sectional analysis of Sahrawi refugees residing in the Tindouf camps, Algeria, who voluntarily attended the Médicos del Mundo (MdM) ophthalmology missions held between 30 September and 13 October 2024, and 6 May and 16 May 2025, due to visual symptoms or ophthalmological problems. This was a non-probability, clinic/mission-based sample of symptomatic or care-seeking individuals. Therefore, the observed proportions should be interpreted as clinic-based frequencies among attendees rather than population prevalence. Age and sex standardisation was performed to approximate potential population burden under camp demographic weights but cannot eliminate selection effects. MdM is a member of the Doctors of the World International Network (https://www.medicosdelmundo.org), a non-governmental organisation dedicated to ensuring the human right to healthcare for refugee populations. Selection of participants and sample size The inclusion criterion was permanent residence in the Tindouf refugee camps and evaluation by MdM’s ophthalmology missions in October 2024 or May 2025 for ophthalmic symptoms or conditions. The final sample comprised 900 patients. Exclusion criteria were limited to non-residents or those lacking a complete ophthalmological assessment. Main and secondary outcomes The primary outcome was the clinic-based frequency of glaucoma in the study group. Secondary outcomes, included for contextual clinical interpretation, comprised the clinic-based frequency and distribution of other common ophthalmic diseases (cataract, keratopathy, retinopathy), as well as the coexistence of these conditions. Data collection and variables All participants underwent a standardised ophthalmological examination, including a symptom-focused medical history (eg, vision loss, pain, discomfort, secretions), assessment of visual acuity (VA) at a distance of 3 m using a Snellen VA chart, slit lamp examination of the anterior and posterior segments with a+90 D Volk lens, and contact tonometry using a rebound tonometer (iCare, Tiolat Oy, Helsinki, Finland) to assess intraocular pressure (IOP). Patients with decreased VA attributable to cataracts underwent keratometry and axial length measurement using the Visionix VX 90 autorefractometer (Visionix, Luneau Technology Group, France), and the OcuScan RxP ultrasonic biometer (Alcon Laboratories, Texas, USA). The following parameters were recorded in a database: VA, IOP, appearance of the optic nerve (glaucomatous or not), presence of pseudoexfoliation and the diagnosis as determined by the ophthalmologist. Additionally, age, gender, and Wilaya of origin were documented for all participants. Glaucoma diagnostic criteria Glaucoma diagnosis was based on structural optic nerve damage consistent with glaucoma and increased IOP. Functional damage assessed by visual field testing was not considered, following criteria used in epidemiological studies and clinical guidelines for resource-limited settings where perimetry is not feasible.8,10 Diagnosis was established by the combination of increased optic cup excavation and elevated IOP. Pathological optic nerve excavation was defined as cup-to-disc ratio greater than 0.7 or an interocular asymmetry of 0.2 or more, in the absence of other causes of optic nerve head damage or non-glaucomatous optic neuropathy. High IOP was defined as >21 mm Hg, consistent with thresholds used in epidemiological studies and international guidelines.11 Given the humanitarian and resource-limited context of the missions, the diagnostic criteria for glaucoma followed a pragmatic, epidemiologically validated approach. Diagnosis relied on structural optic nerve head assessment and IOP measurement, in line with international guidelines for settings where perimetry and advanced imaging are not feasible. To enhance diagnostic consistency and reduce inter-examiner variability, all suspected cases were independently reviewed and confirmed by a second ophthalmologist with specific training in glaucoma. This dual assessment aimed to minimise misclassification, although early-stage disease may still have been under-detected due to the absence of functional testing and structural imaging. Statistical analysis Statistical analysis was conducted using IBM SPSS Statistics software (V.28.0; IBM). Categorical variables were described as frequencies and percentages; continuous variables as mean and SD if normally distributed, or median and IQR if not. Normality was assessed using the Shapiro-Wilk test. For group comparisons, parametric tests (t-test, analysis of variance) were used for continuous variables with normal distribution and non-parametric tests (Mann-Whitney U, Kruskal-Wallis) were used otherwise. χ² tests were applied for categorical variables (eg, gender, Wilaya and coexisting diagnoses). The clinic-based frequency of glaucoma and other ocular diseases was calculated for the total sample and stratified by age group, gender and Wilaya. Bivariate analyses were performed to assess the association between each independent variable and the presence of glaucoma, using crude ORs (CORs) with 95% CIs and p values. Variables with clinical or statistical relevance were then included in a multivariate logistic regression model to estimate adjusted AOR, controlling for potential confounders. The independent factors included were age group, gender, keratopathy, retinopathy, cataract and Wilaya of residence. For the secondary outcomes, descriptive and comparative analyses were conducted as above. As this was a cross-sectional study in which only data from patients who attended for evaluation were collected, there were no missing data. All analyses were performed on complete cases. All statistical tests were two-sided, and a <0.05 was considered statistically significant. Population adjustment of clinic-based frequency The age-and-gender-adjusted clinic-based frequency of glaucoma among attendees was estimated using the formula: Padjusted=i∑(pi×wi), where pi is the observed clinic-based frequency of glaucoma in each age and gender group, and wi is the relative weight of that group in the total population of the camps. The age and gender groups used were: 0–4 years (girls/boys), 5–17 years (boys and girls), 18–49 years (men and women) and ≥50 years (men and women). Adjusted clinic-based frequencies were estimated by direct standardisation across age–gender strata using camp population weights; 95% CIs were calculated using the stratified variance method. Patient and public involvement Patients and members of the public were not involved in the design, conduct, analysis, writing or dissemination plans of this research. Results Findings represent clinic-based frequencies among symptomatic attendees. Data from a total of 900 patients were analysed, of whom 56% (n=508) were men and 44% (n=392) were women. The median age was 70 years (IQR: 16; range: 2–104). Most participants were from Laayone (28.7%; n=258), followed by Smara (27.6%; n=248), Awserd (18.6%; n=168), Boujdour (12.8%; n=115) and Dakhla (10.4%; n=94). In 17 patients (1.9%), the Wilaya of origin could not be identified. Main outcome: clinic-based frequency of glaucoma The overall clinic-based frequency of glaucoma was 13.3% (n=120; 95% CI 11.1 to 15.5%). No statistically significant differences in glaucoma clinic-based frequency were observed between men (12.8%; 95% CI 9.9% to 15.7%) and women (14.0%; 95% CI 10.6% to 17.5%) (p=0.589). No significant differences were found between Wilayas (p=0.060). The majority of glaucoma cases were concentrated among patients aged over 18 years. After adjusting for the population structure of the Sahrawi camps, the age-adjusted and gender-adjusted clinic-based frequency estimate of glaucoma was 6.7% (95% CI 3.8% to 9.7%; see table 1). Table 1Observed and adjusted clinic-based frequency of glaucoma by age group and genderAge–gender groupsPopulation weightGlaucomatous subjects (n)Number of patients (n)Observed clinic-based frequency (%)Adjusted clinic-based frequency (%)Girls 0–40.06010.00.0Boys 5–170.131166.30.8Girls 5–170.130100.00Men 18–490.223437.01.5Women 18–490.234478.52Men ≥500.086544914.51.2Women ≥500.094733913.91.2Glaucoma subjects indicate the number of cases in each age–sex stratum. Observed clinic-based frequency uses the total number of patients or attendees in that stratum as denominator. Adjusted clinic-based frequency applies the age–sex population weights of the camp. The overall adjusted clinic-based frequency was 6.7% (95% CI 3.8% to 9.7%). Observed and adjusted clinic-based frequency of glaucoma by age group and gender Glaucoma subjects indicate the number of cases in each age–sex stratum. Observed clinic-based frequency uses the total number of patients or attendees in that stratum as denominator. Adjusted clinic-based frequency applies the age–sex population weights of the camp. The overall adjusted clinic-based frequency was 6.7% (95% CI 3.8% to 9.7%). Factors associated with glaucoma Bivariate and multivariate analyses to identify risk factors for glaucoma are shown in table 2. Table 2Univariate, bivariate and multivariate analysis for glaucomaVariableCategoryGlaucoma Yes/NoCOR (95% CI)P valueAOR (95% CI)P valueAge (continuous, per year)_120/7800.99 (0.98 to 1.01)0.7921.02 (1.01 to 1.03)0.003GenderMale55/3371.11 (0.76 to 1.64)0.5890.80 (0.53 to 1.22)0.302Female65/4431.00_1.00_KeratopathyNo114/7041.00_1.00_Yes6/760.49 (0.21 to 1.15)0.0990.35 (0.14 to 0.86)0.023RetinopathyNo115/7541.00_1.00_Yes5/261.26 (0.47 to 3.35)0.6420.65 (0.24 to 1.79)p=0.406CataractNo89/2731.00_1.00_Yes31/5070.06 (0.04 to 0.09)<0.00010.14 (0.09 to 0.22)<0.0001WilayaAwserd29/1391.001.00_Boujdour12/1030.08 (0.02 to 0.35)0.0010.55 (0.26 to 1.18)0.125Dakhla12/820.56 (0.27 to 1.16)0.1180.78 (0.36 to 1.69)0.527Laayone36/2220.91 (0.57 to 1.43)0.6750.85 (0.48 to 1.51)0.585Smara31/2170.21 (0.16 to 0.29)<0.00010.68 (0.38 to 1.23)0.204Denominators correspond to the number of attendees with and without glaucoma in each category. Variables included in the multivariable model: age, gender, cataract, keratopathy, retinopathy and wilaya.AOR, adjusted OR; COR, crude OR. Univariate, bivariate and multivariate analysis for glaucoma Denominators correspond to the number of attendees with and without glaucoma in each category. Variables included in the multivariable model: age, gender, cataract, keratopathy, retinopathy and wilaya. AOR, adjusted OR; COR, crude OR. In univariate analysis, age as a continuous variable was not significantly associated with glaucoma (COR per year 0.99; 95% CI 0.98 to 1.01; p=0.792). However, in the multivariate model adjusting for gender, cataract, keratopathy, retinopathy and Wilaya of residence, age showed a significant independent association with glaucoma. In bivariate analyses, the presence of cataract showed an inverse association with glaucoma (COR 0.06; 95% CI 004 to 0.09; p<0.0001. Both cataract and keratopathy showed inverse association with glaucoma in the bivariate and multivariate analyses (see table 2). Secondary outcome: clinic-based frequency and distribution of other ophthalmic diseases The clinic-based frequency of patients presenting one or combinations of the other most frequent ophthalmic diseases (cataract, keratopathy and retinopathy) is shown in table 3. Table 3Clinic-based frequency and number of patients presenting one or combinations of glaucoma and the most frequent ophthalmic diseases (cataract, keratopathy and retinopathy)Disease combinationNumber of patientsClinic-based frequency (%)Cataract alone53859.8 (95% CI 56.5 to 62.9)Glaucoma alone12013.3 (95% CI 11.3 to 15.7)Keratopathy alone829.1 (95% CI 7.4 to 11.2)Retinopathy alone313.4 (95% CI 2.4 to 4.8)Cataract+keratopathy293.2 (95% CI 2.3 to 4.6)Cataract+glaucoma313.4 (95% CI 2.4 to 4.8)Glaucoma+retinopathy50.6 (95% CI 0.2 to 1.3)Glaucoma+keratopathy60.7 (95% CI 0.3 to 1.4)Cataract+retinopathy40.4 (95% CI 0.2 to 1.1)Cataract+glaucoma+keratopathy20.2 (95% CI 0.1 to 0.8)Cataract+glaucoma+retinopathy10.1 (95% CI 0.0 to 0.6)Number of patients and clinic-based frequencies refer to the total sample of care-seeking attendees (n=900); these values do not represent population prevalence. Clinic-based frequency and number of patients presenting one or combinations of glaucoma and the most frequent ophthalmic diseases (cataract, keratopathy and retinopathy) Number of patients and clinic-based frequencies refer to the total sample of care-seeking attendees (n=900); these values do not represent population prevalence. The clinic-based frequencies of other frequent ocular pathologies, observed and adjusted by age and gender groups are detailed in tables46. Table 4Keratopathy—observed and adjusted clinic‑based frequencies by age–sex groupAge–sex groupPopulation weightPatients (n)Subjects with keratopathy (n)Observed clinic-based frequency (%)Adjusted clinic-based frequency (%)Boys 0–40.06100.00.0Boys 5–170.131616.250.81Girls 5–170.1310110.01.3Men 18–490.224336.981.53Women 18–490.234712.130.49Men ≥500.084495211.580.93Women ≥500.09334247.190.65Observed and adjusted clinic-based frequencies use the number of mission attendees in each age–sex stratum as the denominator; these values do not represent population prevalence. Adjusted clinic-based frequencies apply camp population age–sex weights. Strata with zero cases yield an observed clinic-based frequency of 0.0%. Keratopathy—observed and adjusted clinic‑based frequencies by age–sex group Observed and adjusted clinic-based frequencies use the number of mission attendees in each age–sex stratum as the denominator; these values do not represent population prevalence. Adjusted clinic-based frequencies apply camp population age–sex weights. Strata with zero cases yield an observed clinic-based frequency of 0.0%. Table 6Cataract—observed and adjusted clinic‑based frequencies by age–sex groupAge–sex groupPopulation weightPatients (n)Subjects with cataract (n)Observed clinic-based frequency (%)Adjusted clinic-based frequency (%)Boys 0–40.06100.00.0Boys 5–170.131600.00.0Girls 5–170.131000.00.0Men 18–490.224349.32.05Women 18–490.2347919.154.4Men ≥500.0844929064.595.17Women ≥500.0933423570.366.33Observed and adjusted clinic‑based frequencies use the number of mission attendees in each age–sex stratum as the denominator; these values do not represent population prevalence. Adjusted clinic‑based frequencies apply camp population age–sex weights. Strata with zero cases yield an observed clinic‑based frequency of 0.0%. Cataract—observed and adjusted clinic‑based frequencies by age–sex group Observed and adjusted clinic‑based frequencies use the number of mission attendees in each age–sex stratum as the denominator; these values do not represent population prevalence. Adjusted clinic‑based frequencies apply camp population age–sex weights. Strata with zero cases yield an observed clinic‑based frequency of 0.0%. Table 5Retinopathy—observed and adjusted clinic‑based frequencies by age–sex groupAge–sex groupPopulation weightPatients (n)Subjects with retinopathy (n)Observed clinic-based frequency (%)Adjusted clinic-based frequency (%)Boys 0–40.0611100.06.0Boys 5–170.131616.250.81Girls 5–170.131000.00.0Men 18–490.224349.32.05Women 18–490.2347612.772.94Men ≥500.0844992.00.16Women ≥500.09334102.990.27Observed and adjusted clinic‑based frequencies use the number of mission attendees in each age–sex stratum as the denominator; these values do not represent population prevalence. Adjusted clinic‑based frequencies apply camp population age–sex weights. Strata with zero cases yield an observed clinic‑based frequency of 0.0%. Retinopathy—observed and adjusted clinic‑based frequencies by age–sex group Observed and adjusted clinic‑based frequencies use the number of mission attendees in each age–sex stratum as the denominator; these values do not represent population prevalence. Adjusted clinic‑based frequencies apply camp population age–sex weights. Strata with zero cases yield an observed clinic‑based frequency of 0.0%. As with glaucoma, all ophthalmic diseases were more common in older patients. Figure 1 shows the age distribution of patients for each diagnostic group, expressed as median (25th–75th percentile): glaucoma 69 years (58.8–74.2), keratopathy 74 years (66.0–80.0), cataract 72 years (66.0–77.0) and retinopathy 55 years (46.5–68.5). The Kruskal-Wallis test revealed statistically significant differences in age among the four diagnostic groups (H=47.96; p<0.0001). Pairwise post hoc comparisons using the Mann-Whitney U test with Bonferroni correction showed significant differences in age between most groups (adjusted p<0.05); however, no significant differences were observed between cataract and keratopathy or between glaucoma and keratopathy. Age distribution of patients by diagnostic group. Boxplots display the median and IQR (25th–75th percentile) for age in each group: glaucoma, keratopathy, retinopathy and cataract. Whiskers indicate the range excluding outliers, which are represented as individual points. Among coexisting ophthalmic conditions, cataract was the most common (59.8%, n=538), followed by keratopathy (9.1%, n=82) and retinopathy (3.4%, n=31). The retinopathy group included patients with retinal diseases affecting vision (scarring or other macular damage, retinal diseases consistent with vascular problems such as thrombosis or diabetic retinopathy, and retinal detachment). Among the ophthalmic conditions identified, glaucoma accounted for a disproportionate share of irreversible visual loss. The coexistence of two or more ocular diseases was observed in 8.1% of patients, with the most common combinations being cataract and glaucoma (3.4%) and cataract and keratopathy (3.2%) (table 3). Among study participants, 37.8%, n=340 out of 900 patients had severe bilateral visual impairment (VA≤10% in both eyes), while 40.9%, n=368 out of 900 patients had only one functional eye, defined as having a best VA of less than 10% in one eye and greater than 20% in the other. Within the group with low vision in both eyes, the leading causes were cataract (71.1%, n=242 out of 340 patients), glaucoma (17.5%, n=60 out of 340 patients), keratopathy (13.3%, n=45 out of 340 patients) and retinopathy (7.1%, n=24 out of 340 patients). For those with only one functioning eye, cataract accounted for 63.3% of cases, n=233 out of 368 patients, glaucoma for 16.3%, n=60 out of 368 patients, keratopathy for 11.4%, n=42 out of 368 patients and retinopathy for 3%, n=11 out of 368 patients. It is particularly relevant to highlight that 17.5% of patients with bilateral low vision are affected by irreversible blindness in both eyes due to glaucoma. No statistical differences were observed in the proportion of patients with low binocular (p=0.076) or monocular (p=0.236) VA between the main ophthalmic diseases analysed (glaucoma, cataract, keratopathy and retinopathy). In our sample, 31%, 37 out of 120 glaucoma patients had bilateral low vision. Analysis by age group showed that the clinic-based frequency of cataract, glaucoma, monocularity and low binocular vision increased with age (p<0.001 for all comparisons except for low binocular vision, where p=0.005). Online supplemental figure 1 shows the clinic-based frequency of cataract, glaucoma, keratopathy and retinopathy by gender, while online supplemental figure 2 shows the clinic-based frequency of these diseases by Wilaya. No significant differences were found in the clinic-based frequencies of cataract, glaucoma or retinopathy between men and women, (except for keratopathy which was more frequent in men, p=0.023, and low bilateral VA, more frequent in women, p=0.038). In all Wilayas, cataract was the most common eye disease, followed by glaucoma. Cataract was most frequent in Dakhla (p=0.026), but the distribution of other diseases was similar across Wilayas. Population adjustment results The clinic-based frequency of glaucoma in our sample was 13.3%. After adjusting the results according to the Saharawi camp population structure (considering age and gender distribution: 6% children aged 0–4, 13% boys and 13% girls aged 5–17, 22% men and 23% women aged 18–49, and 8% men and 9% women aged 50 or over), the age-adjusted and gender-adjusted clinic-based frequency estimate of glaucoma was 6.7%. This value was obtained by multiplying the observed clinic-based frequency of glaucoma in each age and gender group by the relative weight of that group in the total population and adding the contributions of all population strata. The age-adjusted and gender-adjusted clinic-based frequency estimates of the other most common diseases among participants in this study were as follows: keratopathy: 5.7% (95% CI 2.2% to 9.2%), retinopathy: 12.2% (95% CI 8.9% to 15.5%) and cataract: 17.9% (95% CI 14.7% to 21.2%). Discussion This study provides robust evidence that glaucoma represents a major clinic-based burden among symptomatic Sahrawi refugees attending humanitarian ophthalmology missions in the Tindouf camps. The age-adjusted and sex-adjusted clinic-based frequency of glaucoma based on the demographic structure of the camps was higher than figures reported in international systematic reviews and meta-analyses in low-resource settings and in our region.12 12,18 A substantial proportion of glaucoma patients presented with bilateral low vision, and 17.5% of individuals with bilateral low vision were blind in both eyes due to irreversible glaucomatous damage. In this clinic-based sample, glaucoma therefore represents a major cause of permanent visual disability. Older age was significantly associated with glaucoma after adjustment for coexisting ocular pathology, and many cases were already at an advanced stage. The inverse association observed between glaucoma and either cataract or keratopathy likely reflects diagnostic overshadowing, whereby media opacity or cataract-related visual loss reduces the detectability of glaucomatous structural changes during examination. The high proportion of advanced glaucoma likely reflects structural barriers to healthcare access, diagnostic limitations, and the absence of systematic early-detection strategies in refugee settings. In resource-limited environments, glaucoma is frequently underdiagnosed even when optic-nerve damage is severe. Although our data cannot support causal conclusions, these patterns are consistent with other populations with restricted access to general and ophthalmic care.25 12 15 16 19,22 In addition to glaucoma, coexisting conditions such as cataract, retinopathy and keratopathy highlight the cumulative effects of desert environmental exposure, ageing and systemic comorbidities, as reported in other displaced populations.14 17 20 23 Cataract, as a coexisting condition, was the leading cause of reversible visual disability, and cataract surgery remains highly cost-effective. Keratopathy appeared less frequent, consistent with reports from populations exposed to similar environmental stressors.24,27 As a secondary contextual finding, the age-adjusted and sex-adjusted clinic-based frequency of cataract (17.9%) was consistent with studies from comparable clinical settings.28,31 In contrast to cataract, glaucoma leads to irreversible blindness, underscoring its disproportionate contribution to long-term visual disability when diagnosis and treatment are delayed. From a public-health perspective in humanitarian settings, our results suggest that glaucoma may represent an under-addressed structural burden in refugee populations, where service models commonly prioritise surgically reversible conditions. The lack of systematic screening and limitations in treatment continuity favour the silent accumulation of advanced glaucoma. These findings have practical operational implications. In mission-based and intermittent service delivery models, opportunistic glaucoma detection—including integration within high-volume cataract care pathways—is a feasible and efficient strategy that takes advantage of the large number of patients seeking care for cataract-related visual loss. The follow-up limitations inherent to displaced populations require simplified diagnostic and therapeutic pathways, including treatment initiation during the same clinical visit and culturally adapted instructions supported by community health workers to minimise loss to follow-up. Ensuring continuity of glaucoma medication through prepositioned supplies and coordination with local pharmacies or NGOs is essential when long-term follow-up cannot be guaranteed. Implementing this model does not require highly specialised infrastructure but does require a minimum set of conditions: trained local personnel able to screen for glaucoma, portable ophthalmic equipment (handheld tonometry, slit-lamp examination and low-cost optic-nerve documentation such as non-mydriatic fundus photography), reliable medication and instrument supply chains, and clear referral pathways for complex cases. Beyond reporting clinic-based disease frequencies, our findings outline an adaptable operational framework for integrating glaucoma management into humanitarian eye-care programmes. Equity and safeguarding measures were prioritised throughout the mission, including free care, culturally adapted consent, support from local health personnel who acted as interpreters, confidentiality within the constraints of the camp setting, and established referral circuits for complex cases. Vulnerable groups—older adults, people with disabilities and minors—received additional support to ensure safe access to care. Participants diagnosed with advanced or severe disease received immediate counselling and a clear explanation of their condition and management options. This study has limitations. Given the humanitarian context in which the clinical missions were conducted, all data used in this study were generated during routine patient care rather than for research purposes. As a result, ethical approval was necessarily obtained retrospectively, after the clinical team recognised the disproportionate burden of glaucoma-related visual loss among attendees. Importantly, all information was fully anonymised prior to analysis, in line with data-protection requirements for studies involving vulnerable refugee populations. While these procedures ensured strong safeguards for participant confidentiality, they also limited the possibility of longitudinal follow-up or linkage to individual patient trajectories. Selection bias due to voluntary attendance of symptomatic individuals may overestimate clinic-based frequencies. Glaucoma diagnosis relied on optic-nerve appearance and IOP without visual-field testing, which increases the risk of misclassification, particularly in the presence of media opacity. Although requiring agreement between two ophthalmologists reduced diagnostic variability, both overdiagnosis and underdiagnosis may have occurred, and this should be considered when comparing with studies using more comprehensive diagnostic protocols.8 9 The cross-sectional design and non-random sample limit causal inference, and findings should be interpreted as clinic-based frequencies rather than population prevalence. Although demographic adjustment improves interpretability, these estimates cannot be extrapolated to the broader Sahrawi refugee population. Although the use of a mission-based convenience sample limits the extrapolation of these findings to the general Sahrawi population, the reported clinic-based frequencies offer a high-fidelity snapshot of the actual ophthalmic demand. These results are indispensable for international health organisations to optimise the allocation of diagnostic and surgical resources in the Tindouf camps. In conclusion, this study demonstrates a significant burden of glaucoma with irreversible visual loss, alongside other coexisting causes of visual disability among symptomatic individuals attending humanitarian eye-care missions in the Tindouf refugee camps. Beyond quantifying clinic-based frequencies, our findings highlight the need to integrate feasible strategies for glaucoma detection and treatment continuity within humanitarian ophthalmology programmes to prevent irreversible blindness in this vulnerable population. Supplementary material Acknowledgements The authors gratefully acknowledge the Ministry of Health of the Sahrawi Arab Democratic Republic, Médicos del Mundo (https://www.medicosdelmundo.org/), Dr Tomás Pellicer and Ms Elena Blanco for their invaluable leadership and coordination of the ophthalmology missions in the Sahrawi refugee camps. We also extend our sincere thanks to the more than one hundred volunteers who have contributed to this project over the past 30 years, the Sahrawi Refugee Nursing Association and to the Sahrawi people for their hospitality and warmth. We further thank Dr Enrique Borque, new project coordinator, for his availability and collaboration. We gratefully acknowledge Médicos del Mundo España for enabling the implementation of the fieldwork through their operational, logistical and institutional support within the Sahrawi refugee camps. Footnotes Funding: The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors. Provenance and peer review: Part of a Topic Collection; Not commissioned; externally peer reviewed. Patient consent for publication: Not applicable. Ethics approval: This study received retrospective ethical approval from the Healthcare Ethics Committee of Hospital Clínico San Carlos, Madrid (Protocol 25–-043; approval date 26 September 2025). The Committee reviewed the project during its Standing Committee meeting (Acta 10/2025) and confirmed that the study objectives, methodology and data-handling procedures complied with applicable ethical and legal standards, and the principles of the Declaration of Helsinki.The approval was obtained retrospectively because all clinical information used in this study was originally collected as part of routine humanitarian ophthalmology missions, solely for the purpose of patient care. The research question and analytical design were formulated after the completion of the missions, when the clinical team identified a disproportionate burden of glaucoma-related visual loss in this population. No additional procedures were performed for research purposes.In line with best-practice requirements for research involving vulnerable refugee populations, all data were fully anonymised prior to analysis. Direct identifiers (name, birthdate, household identifiers) were removed at the point of data entry, and only de-identified clinical variables were retained. No potentially identifying information was transferred outside the mission setting. The Healthcare Ethics Committee of Hospital Clínico San Carlos explicitly confirmed that anonymisation procedures and data-security safeguards were adequate for research involving displaced populations.Given the humanitarian context, culturally adapted verbal consent was obtained for clinical care. Because data were derived solely from routine care and were fully anonymised prior to analysis, the Committee determined that written informed consent for research participation was not required. No identifiable information was accessible to the research team at any stage.The research was supported by the humanitarian and medical cooperation organisation MdM and endorsed by the Ministry of Health of the SADR. The contribution of both entities did not influence the analysis or results of the study. Data availability free text: Data may be made available from the corresponding author on reasonable request and subject to approval by the appropriate ethical authorities. Patient and public involvement: Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research. Data availability statement Data are available on reasonable request. References Associated Data Supplementary Materials Data Availability Statement Data are available on reasonable request.